
PT-141 (Bremelanotide) research product
10mg vial, research use only
The PT-141 (Bremelanotide) research product is available in New Zealand for laboratory study.
PT-141 (bremelanotide) is an FDA-approved peptide for women designed to support sexual desire by acting on the brain’s arousal pathways. Unlike traditional treatments that focus on circulation or hormone levels alone, PT-141 works centrally to help restore sexual interest and responsiveness.
About this research peptide
Every peptide in our catalogue is supplied as a lyophilised (freeze-dried) powder in a sealed vial, accompanied by a batch number for full traceability. Before release, each batch is analysed by high-performance liquid chromatography (HPLC) to confirm ≥99% purity and by mass spectrometry (MS) to verify sequence identity. A batch-specific Certificate of Analysis is available on request.
For laboratory use, reconstitute the lyophilised peptide using bacteriostatic water or the solvent specified by your research protocol. Store lyophilised vials at −20°C, protected from light and moisture, and keep reconstituted solutions refrigerated at 2–8°C. Always follow your institution’s laboratory safety procedures and handle these compounds in accordance with all applicable New Zealand regulations.
These products are supplied strictly for in-vitro laboratory research purposes only. They are not medicines or dietary supplements, are not for human or veterinary use, and are not intended to diagnose, treat, cure, or prevent any disease.
All products are sold strictly for laboratory research purposes only. Not for human or veterinary use, and not intended to diagnose, treat, cure, or prevent any disease.
Loading reviews…